🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, double-blind, placebo-controlled, parallel-group stud...
Status
Active Not Recruiting
Location
Shanghai Dermatology Hospital
Start Date
2024-09-23
Trial ID
NCT06554847
Treatments Being Tested
This study will evaluate the effect and safety of 611 in patients with Chro...
Status
Active Not Recruiting
Location
Site 01
Start Date
2024-11-22
Trial ID
NCT06639295
To investigate the effect of rising oral single-doses of BIA 6-512 (25 mg, ...
Status
Completed
Location
Human Pharmacology Unit (UFH)
Start Date
2004-11-03
Trial ID
NCT03091868
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of 40 mg a day of ist...
Status
Completed
Location
Kyowa Hakko UK Ltd.
Start Date
2004-11
Trial ID
NCT00199394
Treatments Being Tested
The purpose of this study is to show that higher minimum concentration valu...
Status
Completed
Location
NEURO
Start Date
2006-12
Trial ID
NCT00693862
Treatments Being Tested
The main goal of PD research is to develop disease-modifying drugs to delay...
Status
Unknown
Location
Second Affilliated Hospital Zhejiang University
Start Date
2022-01-01
Trial ID
NCT04952194
Treatments Being Tested
This trial is designed to study the effects of various mechanistically uniq...
Status
Active Not Recruiting
Location
Vanderbilt University Autonomic Dysfunction Center
Start Date
1997-04
Trial ID
NCT00262470
Treatments Being Tested
This will be a randomised, crossover, double-blind, double-dummy, active-co...
Status
Completed
Location
Clinical Research Services Turku CRST
Start Date
2016-04-08
Trial ID
NCT02764125
Treatments Being Tested
This observational, multicenter, case-control study aims to evaluate the ef...
Status
Recruiting
Location
The First Affiliated Hospital of Guangxi Medical University
Start Date
2025-06-05
Trial ID
NCT06928519
Phase I open, randomized cross-over pharmacokinetic study....
Status
Completed
Location
Clinical Research Services Turku CRST
Start Date
2015-08
Trial ID
NCT02554734
Treatments Being Tested